Synchron

Unlocking the natural highways of the brain.

Visit Website →

Overview

Synchron is a neurotechnology company that is pioneering a new form of brain-computer interface. Their flagship product, the Stentrode, is a small, stent-like device that can be implanted in a blood vessel in the brain without the need for open-brain surgery. Once in place, it can record brain activity and allow individuals with severe paralysis to control computers and other devices with their thoughts. While primarily focused on paralysis, this technology represents a significant advance in neurology.

✨ Key Features

  • Endovascular brain-computer interface (Stentrode)
  • Minimally invasive implant procedure
  • Wireless transmission of brain signals
  • Control of digital devices with thought
  • Does not require open-brain surgery

🎯 Key Differentiators

  • Minimally invasive endovascular approach, avoiding open-brain surgery
  • First company to receive FDA approval for human trials of an endovascular BCI
  • Focus on a practical, near-term solution for patients with paralysis

Unique Value: Offers a revolutionary, minimally invasive way for people with paralysis to reconnect with the digital world.

🎯 Use Cases (3)

Restoring communication for people with paralysis (e.g., from ALS, stroke) Controlling assistive technology Potential future applications in other neurological conditions

✅ Best For

  • Enabling patients with paralysis to text, email, and browse the web

💡 Check With Vendor

Verify these considerations match your specific requirements:

  • Symptom tracking for ambulatory patients with movement disorders

🏆 Alternatives

Neuralink Blackrock Neurotech Paradromics

Provides a significantly safer and more accessible approach to BCI implantation compared to technologies that require a craniotomy.

🔒 Compliance & Security

✓ HIPAA ✓ BAA Available ✓ FDA Investigational Device Exemption (IDE)

💰 Pricing

Contact for pricing
Visit Synchron Website →